Decreased FOXO3a expression correlates with increased cancer cell progression, promoting tumor occurrence, metastasis, and aggressive features in various malignancies, including upper tract urothelial carcinoma (Zhang et al., 2021). The gene discussed is FOXO3; the disease is cancer.